Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country. Sahpra will have to work with the European Medicines Agency on this, as it’s severely understaffed and unable to review medicines speedily.
News24 | Talks have started to get the twice-yearly anti-HIV jab registered in SA
By staff1 Min Read
Keep Reading
© 2024 Times Network. All Rights Reserved.